Status:
UNKNOWN
Continuous Glucose Monitoring for Colorectal Cancer
Lead Sponsor:
Medical University of Gdansk
Conditions:
Continuous Glucose Monitoring
Colorectal Cancer
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Hyperglycemia commonly occurs during surgery due to a reaction to metabolic stress and trauma. It has been shown that improper glycemia control leads to impaired wound healing and a higher risk of oth...
Detailed Description
Hyperglycemia commonly occurs during surgery due to a reaction to metabolic stress and trauma. It has been shown that improper glycemia control leads to impaired wound healing and a higher risk of oth...
Eligibility Criteria
Inclusion
- written informed consent
- confirmed colorectal cancer qualified for surgery
Exclusion
- patients who will be unable or will refuse to express informed concern
- pregnant women
- people undergoing dialysis treatment
Key Trial Info
Start Date :
August 27 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
August 31 2024
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT06011473
Start Date
August 27 2023
End Date
August 31 2024
Last Update
August 31 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
UCC Division of Oncological, Transplant and General Surgery
Gdansk, Pomeranian, Poland, 80-214